AUM $10.79BER 0.44%NAV $203.66Holdings 243Inception Feb 2001
Price Chart
Key Statistics
Previous Close
$203.72Day Range
$199.29$205.99
52-Week Range
$160.41$221.13
Avg Volume
2.1MDividend Yield
0.17%Expense Ratio
0.44%AUM
$10.79BShares Outstanding
52.7METF Grades
?ETF Grades compare this fund against others in the same category using percentile rankings across six factors. Grades range from A+ (top 5%) to F (bottom 20%). Updated daily.Sector Breakdown
| Sector | Weight % |
|---|---|
| Biotechnology | 88.09% |
| Life Sciences Tools & Services | 8.53% |
| Pharmaceuticals | 3.05% |
| Health Care Services | 0.15% |
| Cash and/or Derivatives | 0.10% |
| Health Care Equipment | 0.08% |
Country Allocation
| Country | Weight % |
|---|---|
| United States | 94.41% |
| Denmark | 1.98% |
| United Kingdom | 1.62% |
| Canada | 0.46% |
| France | 0.44% |
| Netherlands | 0.29% |
| Switzerland | 0.27% |
| China | 0.17% |
| Spain | 0.14% |
| Ireland | 0.09% |
| Australia | 0.07% |
| Italy | 0.05% |
| Taiwan | 0.00% |
Fund Information
- Issuer
- iShares
- Category
- Biotechnology
- Types
- Biotech
- Inception Date
- Feb 5, 2001
- Exchange
- NASDAQ
- Description
- The iShares Biotechnology ETF seeks to track the investment results of an index composed of U.S.-listed equities in the biotechnology sector.
The iShares Biotechnology ETF (IBB) is an exchange-traded fund issued by iShares that launched on Feb 5, 2001. It currently manages $10.79B in assets under management. The fund charges an expense ratio of 0.44%. The fund holds 243 securities in its portfolio. It falls under the Biotechnology category.
Top 10 holdings represent 51.3% of the fund
| Rank | Symbol | Name | Weight % | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | GILD | GILEAD SCIENCES | 9.32% | 6,005,294 | $1.00B |
| 2 | AMGN | AMGEN INC | 8.36% | 2,044,327 | $897.1M |
| 3 | VRTX | VERTEX PHARMACEUTICALS | 7.83% | 1,613,927 | $840.3M |
| 4 | REGN | REGENERON PHARMACEUTICALS | 6.63% | 770,736 | $711.7M |
| 5 | MRNA | MODERNA | 5.28% | 2,840,798 | $566.3M |
| 6 | ARGX | ARGENX SE ADR | 3.79% | 432,083 | $407.0M |
| 7 | NTRA | NATERA | 2.83% | 1,047,006 | $303.5M |
| 8 | BIIB | BIOGEN | 2.63% | 1,140,433 | $281.8M |
| 9 | ONC | BEONE MEDICINES AG | 2.44% | 654,109 | $261.4M |
| 10 | INSM | INSMED | 2.25% | 1,672,876 | $241.7M |
| 11 | RVMD | REVOLUTION MEDICINES | 2.23% | 1,499,128 | $239.0M |
| 12 | ILMN | ILLUMINA INC | 2.19% | 1,171,149 | $235.0M |
| 13 | GMAB | GENMAB SPONSORED ADR | 2.06% | 4,307,410 | $221.2M |
| 14 | INCY | INCYTE CORP | 1.69% | 1,562,039 | $181.0M |
| 15 | UTHR | UNITED THERAPEUTICS | 1.68% | 322,394 | $180.3M |
Page 1 of 5
Detailed Returns
| Period | Return | ETF |
|---|---|---|
| 1D | -1.98% | |
| 1W | -4.06% | |
| 1M | -3.95% | |
| 3M | -6.11% | |
| 6M | +17.78% | |
| YTD | +18.07% | |
| 1Y | +17.58% | |
| 3Y | +67.17% | |
| 5Y | +30.08% |
Moving Averages
20-Day MA
$212.56
Below 20-Day MA50-Day MA
$208.81
Below 50-Day MA200-Day MA
$187.59
Above 200-Day MAPrice with Moving Averages
Support & Resistance
52-Week High
$221.13
Current Price
$199.58
52-Week Low
$160.41
$160.41$221.13
Current Yield
0.17%
Annual Dividend
$0.2786
Frequency
4x/year
Last Ex-Date
Sep 15, 2026
Dividend History
| Ex-Date | Amount | Pay Date |
|---|---|---|
| Sep 15, 2026 | $0.0112 | Sep 18, 2026 |
| Jun 15, 2026 | $0.0238 | Jun 18, 2026 |
| Mar 17, 2026 | $0.1218 | Mar 20, 2026 |
| Mar 17, 2026 | $0.1218 | Mar 20, 2026 |
| Dec 16, 2025 | $0.1831 | Dec 19, 2025 |
| Dec 16, 2025 | $0.1831 | Dec 19, 2025 |
| Sep 16, 2025 | $0.0828 | Sep 19, 2025 |
| Mar 18, 2025 | $0.1212 | Mar 21, 2025 |
| Mar 18, 2025 | $0.1212 | Mar 21, 2025 |
| Dec 17, 2024 | $0.0624 | Dec 20, 2024 |
| Sep 25, 2024 | $0.2005 | Sep 30, 2024 |
| Sep 25, 2024 | $0.2005 | Sep 30, 2024 |
| Mar 21, 2024 | $0.1260 | Mar 27, 2024 |
| Mar 21, 2024 | $0.1260 | Mar 27, 2024 |
| Dec 20, 2023 | $0.1240 | Dec 27, 2023 |
| Sep 26, 2023 | $0.1532 | Oct 2, 2023 |
| Sep 26, 2023 | $0.1532 | Oct 2, 2023 |
| Jun 7, 2023 | $0.0062 | Jun 13, 2023 |
| Mar 23, 2023 | $0.0646 | Mar 29, 2023 |
| Dec 13, 2022 | $0.1014 | Dec 19, 2022 |
Dividend Payments Over Time
Category Comparison
| Metric | IBB | Biotechnology(1 ETFs) | Biotech(41 ETFs) |
|---|---|---|---|
| Fund Info | |||
| Expense Ratio | 0.44% | 0.44% | 0.86% |
| AUM | $10.79B | $10.79B | $1.89B |
| Dividend Yield | 0.17% | 0.17% | 1.97% |
| Avg Volume | 2.1M | 2.1M | 1.4M |
| Holdings | 243 | 243 | 63 |
| Performance | |||
| 1-Month Return | -4.77% | -4.77% | -8.04% |
| 6-Month Return | +20.26% | +20.26% | +5.24% |
| YTD Return | +18.23% | +18.23% | +8.75% |
| 1-Year Return | +14.65% | +14.65% | +6.36% |
Compare with Another ETF
Search for an ETF to compare with IBB:
FREE DOWNLOAD
The Beginner's Guide to ETFs
20 pages. Zero fluff. Everything you need to start investing in ETFs.
No spam. Unsubscribe anytime.